Q&A: Syngenta's Erik Legg on Why Next-Gen Sequencing Is 'Beyond a Trend' in the Ag-bio Industry
November 30, 2010
Q&A: Syngenta's Erik Legg on Why Next-Gen Sequencing Is 'Beyond a Trend' in the Ag-bio Industry
Recently, In Sequence spoke with Syngenta's head of Omics Application and Research about how the ag-bio giant is making use of sequencing technology, the types of projects it is doing, and how the technology is advancing plant genomics.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Q&A: ARUP Labs' Karl Voelkerding Discusses Bringing Next-Gen Sequencing to the Clinical Setting
March 30, 2010 / In Sequence - Assemblies of E. coli Genome Yield Information Important for Dx Development, Tracing Outbreak
June 14, 2011 / In Sequence - Researchers ID Variants in Hereditary Breast Cancer via Targeted Resequencing of Candidate Regions
April 13, 2010 / In Sequence - New Desktop Sequencer Comparison Suggests 'Two-Horse Race' Between MiSeq, PGM
April 9, 2013 / In Sequence - Comparison Suggests 454, Illumina, and SOLiD Sequences Each Harbor SNVs Missed by Other Two Platforms
February 12, 2013 / In Sequence